Search

We report the results of a retrospective study of a group of 27 patients with a myopathy who were ventilated at home using a nasal mask over a period of 5 years. Twelve patients were ventilated in a preventive fashion before any orthopaedic surgical intervention and 15 out of necessity because of respiratory failure and/or hypercapnia. There was a statistically significant improvement in the PaO2 while the PaCO2 remained stable. The vital capacity (CV) was unaltered. Side effects were relatively frequent but did not lead to this method of ventilation being stopped. One patient died from a very advanced cardio-myopathy after having stopped his own assisted ventilation. Another patient died at home of bronchial congestion. One patient had a tracheotomy after 3 years of ventilation. The treatment was judged overall as positive amongst the 19 patients who responded to a questionnaire anonymously. We are able to confirm the efficacy of this mode of ventilation by the nasal route as much therapeutically as prophylactically, which is against the recently reported results in a multi-centre study.

Since 1970, 168 patients, mostly of the obstructive type, received an apparatus of assisted ventilation at home, according to the degree of their hypoxia-hypercapnia, following one or several acute failures. Oral ventilation, at a daily minimum of 90 min, distributed in 4 to 8 sessions, was continued for variable duration, from 1 to 5 years. The results, analysed statistically for 40 subjects, show a blood-gas improvement greater in patients whose PaO2, PaCO2 and RV/TC ratio were initially lower. For 17 patients controlled before and after assisted ventilation at home, a reduction in the number of days of hospitalization and acute failures was observed. The cost involved was particulary economical because of the simplicity of the equipment and the possibilities of control of patients and apparatus at the C.H.U. (20 F monthly in 1977 for 145 selected patients).